Comparative activity of cloxacillin and vancomycin against methicillin-susceptible Staphylococcus aureus experimental endocarditis

被引:16
|
作者
Fernandez Guerrero, Manuel L. [1 ]
de Gorgolas, Miguel [1 ]
机构
[1] Univ Autonoma Madrid, Dept Internal Med, Div Infect Dis, Fdn Jimenez Diaz, Madrid, Spain
关键词
beta-lactamase-resistant penicillins; glycopeptides; bactericidal activity; staphylococcal bacteraemia;
D O I
10.1093/jac.dkl355
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: To compare the activity of cloxacillin and vancomycin against methicillin-susceptible Staphylococcus aureus and to determine how rapidly their bactericidal activity occurs in cardiac vegetations. Methods: In vitro and in vivo studies using an experimental model of endocarditis in rabbits. Animals were treated for 1, 2 or 3 days with cloxacillin 200 mg/kg intramuscularly three times a day or vancomycin 25 mg/kg intravenously twice a day. Results: Cloxacillin and vancomycin at concentrations 4- and 16-fold the MIC produced a modest decrease in the number of microorganisms at 4 h. After 24 h, cloxacillin produced a decrease in the counts of staphylococci from 2.19 to 4.84 log(10) cfu/mL of inoculum. Only concentrations of vancomycin from 16- to 32-fold the MIC resulted in equivalent decreases. After 24 h of treatment, both antibiotics were equally effective in preventing mortality of rabbits. Cloxacillin produced a greater decrease in the number of staphylococci than vancomycin (3.50 +/- 2.18 log(10) cfu/g vegetation and 6.25 +/- 1.28 log(10) cfu/g vegetation, respectively; P < 0.05) and 41% of rabbits had sterile vegetations in comparison with none with vancomycin (P = 0.035). After 48 and 72 h of treatment, both antimicrobials exhibited equivalent activity. Conclusions: Vancomycin was less rapidly bactericidal than cloxacillin in vivo.
引用
收藏
页码:1066 / 1069
页数:4
相关论文
共 50 条
  • [1] Effectiveness of vancomycin plus cloxacillin compared with vancomycin, cloxacillin and daptomycin single therapies in the treatment of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in a rabbit model of experimental endocarditis
    Castaneda, Ximena
    Garcia-De-la-Maria, Cristina
    Gasch, Oriol
    Pericas, Juan M.
    Soy, Dolors
    Canas-Pacheco, Maria-Alejandra
    Falces, Carlos
    Garcia-Gonzalez, Javier
    Hernandez-Meneses, Marta
    Vidal, Barbara
    Almela, Manel
    Quintana, Eduard
    Tolosana, Jose M.
    Fuster, David
    Llopis, Jaume
    Dahl, Anders
    Moreno, Asuncion
    Marco, Francesc
    Miro, Jose M.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2021, 76 (06) : 1539 - 1546
  • [2] Endocarditis caused by methicillin-susceptible Staphylococcus aureus with reduced susceptibility to vancomycin: A case report
    Perazzi B.
    Bello N.
    Mollerach M.
    Vay C.
    Lasala M.B.
    Famiglietti A.
    Journal of Medical Case Reports, 5 (1)
  • [3] Daptomycin is more efficacious than vancomycin against a methicillin-susceptible Staphylococcus aureus in experimental meningitis
    Gerber, P
    Stucki, A
    Acosta, F
    Cottagnoud, M
    Cottagnoud, P
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 57 (04) : 720 - 723
  • [4] Effect of Vancomycin Minimal Inhibitory Concentration on the Outcome of Methicillin-Susceptible Staphylococcus aureus Endocarditis
    Cervera, Carlos
    Castaneda, Ximena
    Garcia de la Maria, Cristina
    del Rio, Ana
    Moreno, Asuncion
    Soy, Dolors
    Manuel Pericas, Juan
    Falces, Carlos
    Armero, Yolanda
    Almela, Manel
    Ninot, Salvador
    Carlos Pare, Juan
    Mestres, Carlos A.
    Gatell, Jose M.
    Marco, Francesc
    Miro, Jose M.
    CLINICAL INFECTIOUS DISEASES, 2014, 58 (12) : 1668 - 1675
  • [5] Cefazolin versus cloxacillin in methicillin-susceptible Staphylococcus aureus endocarditis: Too good to be true? Authors' reply
    Herrera-Hidalgo, Laura
    de Alarcon, Aristides
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2024, 142
  • [6] EFFICACY OF OFLOXACIN, CIPROFLOXACIN, PEFLOXACIN AND VANCOMYCIN FOR EXPERIMENTAL ENDOCARDITIS CAUSED BY A METHICILLIN-SUSCEPTIBLE STAPHYLOCOCCUS-AUREUS STRAIN
    DEWACHTER, P
    PHELISSE, F
    VOIRIOT, P
    WEBER, M
    TROMEL, H
    DUREUX, JB
    MEDECINE ET MALADIES INFECTIEUSES, 1991, 21 (10): : 633 - 637
  • [7] Levofloxacin versus ciprofloxacin, flucloxacillin, or vancomycin for treatment of experimental endocarditis due to methicillin-susceptible or -resistant Staphylococcus aureus
    Entenza, JM
    Vouillamoz, J
    Glauser, MP
    Moreillon, P
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (08) : 1662 - 1667
  • [8] TEICOPLANIN VERSUS NAFCILLIN AND VANCOMYCIN IN THE TREATMENT OF EXPERIMENTAL ENDOCARDITIS CAUSED BY METHICILLIN-SUSCEPTIBLE OR METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS
    CHAMBERS, HF
    SANDE, MA
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (01) : 61 - 64
  • [9] Comparative Efficacies of Cloxacillin-Daptomycin and the Standard Cloxacillin-Rifampin Therapies against an Experimental Foreign-Body Infection by Methicillin-Susceptible Staphylococcus aureus
    El Haj, Cristina
    Murillo, Oscar
    Ribera, Alba
    Vivas, Mireia
    Garcia-Somoza, Dolors
    Tubau, Fe
    Cabo, Javier
    Ariza, Javier
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (09) : 5576 - 5580
  • [10] Methicillin-Susceptible, Vancomycin-Resistant Staphylococcus aureus, Brazil
    Panesso, Diana
    Planet, Paul J.
    Diaz, Lorena
    Hugonnet, Jean-Emmanuel
    Tran, Truc T.
    Narechania, Apurva
    Munita, Jose M.
    Rincon, Sandra
    Carvajal, Lina P.
    Reyes, Jinnethe
    Londono, Alejandra
    Smith, Hannah
    Sebra, Robert
    Deikus, Gintaras
    Weinstock, George M.
    Murray, Barbara E.
    Rossi, Flavia
    Arthur, Michel
    Arias, Cesar A.
    EMERGING INFECTIOUS DISEASES, 2015, 21 (10) : 1844 - 1848